Mostrar el registro sencillo

dc.contributor.authorBasaia, Silviaes_ES
dc.contributor.authorAgosta, Federicaes_ES
dc.contributor.authorDíez, Ibaies_ES
dc.contributor.authorBueichekú, Elisendaes_ES
dc.contributor.authorD'Oleire Uquillas, Federicoes_ES
dc.contributor.authorDelgado Alvarado, Manueles_ES
dc.contributor.authorCaballero-Gaudés, Césares_ES
dc.contributor.authorRodriguez-Oroz, Mari Cruzes_ES
dc.contributor.authorStojkovic, Tanjaes_ES
dc.contributor.authorKostic, Vladimir S.es_ES
dc.contributor.authorFilippi, Massimoes_ES
dc.contributor.authorSepulcre, Jorgees_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-06-16T13:44:54Z
dc.date.available2022-06-16T13:44:54Z
dc.date.issued2022es_ES
dc.identifier.issn2213-1582es_ES
dc.identifier.urihttp://hdl.handle.net/10902/25118
dc.description.abstractThe genetic traits that underlie vulnerability to neuronal damage across specific brain circuits in Parkinson's disease (PD) remain to be elucidated. In this study, we characterized the brain topological intersection between propagating connectivity networks in controls and PD participants and gene expression patterns across the human cortex - such as the SNCA gene. We observed that brain connectivity originated from PD-related pathology epicenters in the brainstem recapitulated the anatomical distribution of alpha-synuclein histopathology in postmortem data. We also discovered that the gene set most related to cortical propagation patterns of PD-related pathology was primarily involved in microtubule cellular components. Thus, this study sheds light on new avenues for enhancing detection of PD neuronal vulnerability via an evaluation of in vivo connectivity trajectories across the human brain and successful integration of neuroimaging-genetic strategies.es_ES
dc.description.sponsorshipAcknowledgment: The authors thank the patients and their families for the time and effort they dedicated to the research. Funding This research was supported by grants from the National Institutes of Health (NIH; R01AG061811, and R01AG061445 to J.S.), the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant number 175090), the Italian Ministry of Health (grant number RF-2018-12366746), the Carlos III Institute of Health (PI11/02109) Spain, the Basque Government through the BERC 2018-2021 program and the Spanish State Research Agency through BCBL Severo Ochoa excellence accreditation SEV-2015-0490.es_ES
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights© 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceNeuroImage: Clinical Volume 33, 2022, 102941es_ES
dc.subject.otherParkinson’s diseasees_ES
dc.subject.otherfMRIes_ES
dc.subject.otherConnectomicses_ES
dc.subject.otherCortical Gene Expressiones_ES
dc.titleNeurogenetic traits outline vulnerability to cortical disruption in Parkinson's diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1016/j.nicl.2022.102941es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.nicl.2022.102941es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International